• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Eur Rev Med Pharmacol Sci . Lung cavitation as a consequence of coronavirus-19 pneumonia

tetano

Editor, Senior Moderator
Eur Rev Med Pharmacol Sci


. 2021 Oct;25(19):5936-5941.
doi: 10.26355/eurrev_202110_26870.
Lung cavitation as a consequence of coronavirus-19 pneumonia


E Kurys-Denis[SUP] 1 [/SUP], A Grzywa-Celińska, R Celiński



Affiliations

Abstract

Objective: There are reports confirming that the development of pulmonary cavities is an atypical CT finding in patients after COVID-19 pneumonia. Before the SARS-Cov-2 pandemic, we knew that the most common causes of pulmonary cavities were mycobacterial, fungal or parasitic infections. Rapidly increasing incidence of pneumonia in the course of COVID-19, and thus, tomographic examinations of the lungs proved that one of the rare complications of this disease may also be cavity development. The aim of the study was to assess the incidence of pulmonary cavities in patients after SARS-CoV-2 pneumonia. We also aimed to analyze the changes accompanying the pulmonary cavities in our patients.
Patients and methods: We performed a retrospective analysis of 206 lung CT scans of patients with SARS-CoV-2 infection. In 28 of them, prior radiological examination revealed the presence of pulmonary lesions - these patients were disqualified for the study.
Results: Out of 178 enrolled patients, 6 developed pulmonary cavities (3.37% of all cases). The most frequent changes coexisting with cavitary lesions in our material were: ground glass opacities, reticular pattern, bronchiolectasis and subpleural bands.
Conclusions: Our study confirms the similar incidence of pulmonary cavities after COVID-19 than previously reported. It also incites the clinicians to pay attention to the possibility of the occurrence of this complication.
 
Back
Top Bottom